Q&A: Beckman Coulter’s test for myocardial infarction

MTI News spoke to Kathleen Orland, senior vice president and general manager for Beckman Coulter’s clinical chemistry immunoassay about the key role of Access hsTnI assay to detect at-risk patients earlier and discharge non-acute patients faster.

Show CommentsClose Comments

Leave a comment

%d bloggers like this: